Next Article in Journal
A Single Visualization Technique for Displaying Multiple Metabolite–Phenotype Associations
Previous Article in Journal
The Search for Clinically Useful Biomarkers of Complex Disease: A Data Analysis Perspective
Open AccessArticle

Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts

1
Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA 02114, USA
2
Faculty of Medicine, University of Coimbra, 3000 Coimbra, Portugal
3
Centro Hospitalar e Universitário de Coimbra, 3000 Coimbra, Portugal
4
Association for Innovation and Biomedical Research on Light and Image, 3000 Coimbra, Portugal
5
Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
6
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
7
Systems Genetics and Genomics Unit, Channing Division of Network Medicine Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
8
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to the study.
These authors contributed equally to the study.
Metabolites 2019, 9(7), 127; https://doi.org/10.3390/metabo9070127
Received: 5 June 2019 / Revised: 27 June 2019 / Accepted: 28 June 2019 / Published: 2 July 2019
The pathogenesis of age-related macular degeneration (AMD), a leading cause of blindness worldwide, remains only partially understood. This has led to the current lack of accessible and reliable biofluid biomarkers for diagnosis and prognosis, and absence of treatments for dry AMD. This study aimed to assess the plasma metabolomic profiles of AMD and its severity stages with the ultimate goal of contributing to addressing these needs. We recruited two cohorts: Boston, United States (n = 196) and Coimbra, Portugal (n = 295). Fasting blood samples were analyzed using ultra-high performance liquid chromatography mass spectrometry. For each cohort, we compared plasma metabolites of AMD patients versus controls (logistic regression), and across disease stages (permutation-based cumulative logistic regression considering both eyes). Meta-analyses were then used to combine results from the two cohorts. Our results revealed that 28 metabolites differed significantly between AMD patients versus controls (false discovery rate (FDR) q-value: 4.1 × 10−2–1.8 × 10−5), and 67 across disease stages (FDR q-value: 4.5 × 10−2–1.7 × 10−4). Pathway analysis showed significant enrichment of glycerophospholipid, purine, taurine and hypotaurine, and nitrogen metabolism (p-value ≤ 0.04). In conclusion, our findings support that AMD patients present distinct plasma metabolomic profiles, which vary with disease severity. This work contributes to the understanding of AMD pathophysiology, and can be the basis of future biomarkers and precision medicine for this blinding condition. View Full-Text
Keywords: age-related macular degeneration; metabolomics; mass spectrometry age-related macular degeneration; metabolomics; mass spectrometry
Show Figures

Figure 1

MDPI and ACS Style

Laíns, I.; Chung, W.; Kelly, R.S.; Gil, J.; Marques, M.; Barreto, P.; Murta, J.N.; Kim, I.K.; Vavvas, D.G.; Miller, J.B.; Silva, R.; Lasky-Su, J.; Liang, L.; Miller, J.W.; Husain, D. Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts. Metabolites 2019, 9, 127.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop